Prof. Michal Besser

The Besser lab is specialized in the clinical production of CAR T cells and Tumor Infiltrating Lymphocytes (TIL) for therapy of cancer patients.

Adoptive cell therapy serves as a platform for a wide range of research projects, which mainly seek the understanding and improvement of cellular therapies and immunotherapy. 
Research activities include among others the development of off-the-shelf CAR T cells, new constructs for CAR T cells, identification of neo-antigen reactive T cells and the search for predictive markers of clinical response.  

Contact Information:

Dr. Michal Besser PhD

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>